Inactive Instrument

MPX Bioceutical Corp Stock price Canadian Securities Exchange

Equities

CA1353721006

Sales 2017 4.38 5.97 Sales 2018 21.33 29.04 Capitalization 252M 343M
Net income 2017 -5M -6.81M Net income 2018 -17M -23.14M EV / Sales 2017 25,317,482 x
Net cash position 2017 6.67M 9.08M Net Debt 2018 26.91M 36.63M EV / Sales 2018 13,065,112 x
P/E ratio 2017
-7.75 x
P/E ratio 2018
-11.4 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
IAnthus and MPX Bioceutical Receives Demand for Payment and Notice of Intention to Enforce Security CI
IAnthus Capital Holdings, Inc. completed the acquisition of MPX Bioceutical Corporation. CI
MPX Bioceutical Corporation completed the spin off of MPX International Corporation for CAD 56.6 million. CI
MPX Bioceutical Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
MPX Bioceutical Corporation Expands Maryland Footprint with Opening of Health for Life White Marsh Dispensary CI
­ ­ iAnthus Capital Holdings, Inc. and MPX Bioceutical Corporation Signs Arrangement Agreement CI
IAnthus Capital Holdings, Inc. entered into an agreement to acquire MPX Bioceutical Corporation for approximately CAD 520 million. CI
MPX Bioceutical Corporation signed an arrangement agreement to spin off MPX International Corporation. CI
MPX Bioceutical Corporation Opens its New Health for Life Dispensary in Baltimore, Maryland CI
MPX Bioceutical Corporation completed the acquisition of Spartan Wellness Corporation from Ninth Square Capital Corporation and Veteran Grown Corporation. CI
MPX Bioceutical Corporation entered into a binding share purchase agreement to acquire Spartan Wellness Corporation from Ninth Square Capital Corporation and Veteran Grown Corporation for CAD 2.9 million. CI
MPX Bioceutical Corporation Provides Update on GreenMart of Nevada NLV LLC CI
Canada's maturing Big Weed hits up Europe hoping for expansion cash RE
MPX Bioceutical Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2018 CI
MPX Bioceutical Corporation Announces Opening of its First Health for Life Dispensary in Maryland CI
More news
MPX Bioceutical Corp, formerly Canadian Bioceutical Corp, is Canada-based company which produces nutraceutical products intended for the treatment of chronic medical conditions where existing treatments fail to meet the needs of patients or where consumers prefer herbal and plant-based medicines out of their concern for the side effects associated with modern pharmaceutical medicines. Its products include CinG-X, Relieva and FertaMax. CinG-X combines standardized cinnamon and ginseng extracts. CinG-X is also an additive that enhances the value of any food, beverage or nutritional supplement and can be combined with various other ingredients. The Company's extract, Psorberine, has been incorporated into both topical cream and lotion products sold under the brand name Relieva. The Company intends to acquire companies engaged in the supply of management and logistical services to medical marijuana dispensaries, production and cultivation businesses in the United States.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock MPX Bioceutical Corp
  4. Stock MPX Bioceutical Corp - Canadian Securities Exchange